This announcement is a separate document:
诺诚健华医药有限公司自愿披露关于ICP-488 Ⅱ期临床试验结果的公告
Announcement on voluntary disclosure of ICP-488 phase II clinical trial results by Nuochengjianhua Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated